Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 3286 AL 3300

Progressive supranuclear palsy: an updated approach on diagnosis, treatment, risk factors and outlook in Mexico

Gómez-Virgilio L, Gutiérrez-Malacara AI, Rivera-Osorio J, Silva-Lucero MDC, Padilla-Mendoza JR, Gómez-Ramírez DE, Cárdenas-Aguayo MDC.

Gac Med Mex. 2024;160(4):374-383. doi: 10.24875/GMM.M24000930.

Post-translational Modification of α-Synuclein Modifies Monomer Dynamics and Aggregation Kinetics

Gamage K, Wang B, Hard ER, Van T, Galesic A, Phillips GR, Pratt M, Lapidus LJ.

bioRxiv [Preprint]. 2024 May 9:2024.05.06.592473. doi: 10.1101/2024.05.06.592473.

Longitudinal Network Changes and Phenoconversion Risk in Isolated REM Sleep Behavior Disorder

Eidelberg D, Tang C, Nakano Y, Vo A, Nguyen N, Schindlbeck K, Poston K, Gagnon JF, Postuma R, Niethammer M, Ma Y, Peng S, Dhawan V.

Res Sq [Preprint]. 2024 May 28:rs.3.rs-4427198. doi: 10.21203/rs.3.rs-4427198/v1.

Alpha-synuclein regulates nucleolar DNA double-strand break repair in melanoma

Arnold MR, Cohn GM, Oxe KC, Elliott SN, Moore C, Laraia PV, Shekoohi S, Brownell D, Meshul CK, Witt SN, Larsen DH, Unni VK.

bioRxiv [Preprint]. 2024 Jan 14:2024.01.13.575526. doi: 10.1101/2024.01.13.575526.

A Large Harmonized Upper and Lower Limb Accelerometry Dataset: A Resource for Rehabilitation Scientists

Miller AE, Lohse KR, Bland MD, Konrad JD, Hoyt CR, Lenze EJ, Lang CE.

medRxiv [Preprint]. 2024 Aug 16:2024.08.15.24312066. doi: 10.1101/2024.08.15.24312066.

5-HT1B receptors mediate dopaminergic inhibition of vesicular fusion and GABA release from striatonigral synapses

Molinari M, Lieberman OJ, Sulzer D, Santini E, Borgkvist A.

bioRxiv [Preprint]. 2024 Mar 14:2024.03.14.584991. doi: 10.1101/2024.03.14.584991.

Shedding light on gene therapy of Parkinson's disease in non-human primates

Yan X, Jin X.

Innovation (Camb). 2024 Jan 24;5(2):100581. doi: 10.1016/j.xinn.2024.100581. eCollection 2024 Mar 4.

RAB12-LRRK2 Complex Suppresses Primary Ciliogenesis and Regulates Centrosome Homeostasis in Astrocytes

Li X, Zhu H, Huang BT, Li X, Kim H, Tan H, Zhang Y, Choi I, Peng J, Xu P, Sun J, Yue Z.

bioRxiv [Preprint]. 2024 Jul 19:2024.07.17.603999. doi: 10.1101/2024.07.17.603999.

Understanding role of pesticides in development of Parkinson's disease: Insights from Drosophila and rodent models

Afsheen S, Rehman AS, Jamal A, Khan N, Parvez S.

Ageing Res Rev. 2024 Jul;98:102340. doi: 10.1016/j.arr.2024.102340. Epub 2024 May 15.

Prevention of Parkinson's Disease: From Risk Factors to Early Interventions

Ng MG, Chan BJL, Koh RY, Ng KY, Chye SM.

CNS Neurol Disord Drug Targets. 2024;23(6):746-760. doi: 10.2174/1871527322666230616092054.

High Mobility Group Box 1 Protein: A Plausible Therapeutic Molecular Target in Parkinson's Disease

Goyal A, Agrawal A, Dubey N, Verma A.

Curr Pharm Biotechnol. 2024;25(8):937-943. doi: 10.2174/1389201025666230905092218.

Exercise as medicine in Parkinson's disease

Langeskov-Christensen M, Franzén E, Grøndahl Hvid L, Dalgas U.

J Neurol Neurosurg Psychiatry. 2024 Oct 16;95(11):1077-1088. doi: 10.1136/jnnp-2023-332974.

Leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson's disease: a patent review of the literature to date

Morez M, Lara Ordóñez AJ, Melnyk P, Liberelle M, Lebègue N, Taymans JM.

Expert Opin Ther Pat. 2024 Sep;34(9):773-788. doi: 10.1080/13543776.2024.2378076. Epub 2024 Jul 19.

Gut Microbiota and Immune System Dynamics in Parkinson's and Alzheimer's Diseases

Kustrimovic N, Balkhi S, Bilato G, Mortara L.

Int J Mol Sci. 2024 Nov 13;25(22):12164. doi: 10.3390/ijms252212164.

Precision Medicine in Parkinson's Disease Using Induced Pluripotent Stem Cells

Kim MS, Kim H, Lee G.

Adv Healthc Mater. 2024 Aug;13(21):e2303041. doi: 10.1002/adhm.202303041. Epub 2024 Feb 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias